STERIS' (STE) fourth-quarter fiscal 2020 results reflect strong segmental performance despite the coronavirus-led economic crisis.
Vanderbilt University School of Medicine,Professor of Medicine in the Division of Infectious Diseases Dr. William Schaffner joins Yahoo Finance’s Seana Smith to discuss the coronavirus, as a quarter of Americans say they are nervous about a vaccine, according to a new Reuters/Ipsos poll.
STERIS (STE) continues to register stellar organic growth across all four operating segments.
Zacks.com featured highlights include: Medtronic, STERIS and Enova International
Steris , a medical equipment company, announced Friday that the Food and Drug Administration has issued an emergency use authorization for its product that decontaminates N95 mask respirators. The respirators, of course, are used by healthcare providers helping coronavirus patients. "The EUA enables healthcare providers to decontaminate N95 Respirators on-site by utilizing certain Steris V-PRO low temperature sterilization systems," the company said in a statement.
U.S. FDA Grants Emergency Use AuthorizationSTERIS Creates New Decontamination Cycle that Allows Hospitals to Use Their Existing Steam Sterilizers DUBLIN, IRELAND, May 26,.
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors continue to be optimistic about STERIS (STE) on its strong segmental growth in the third quarter of 2020.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Steris (STE) delivered earnings and revenue surprises of 4.46% and 4.39%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
U.S. FDA Grants Emergency Use AuthorizationSolution Leverages Existing Equipment to Allow Hospitals to Decontaminate On-site DUBLIN, IRELAND, April 10, 2020 -- STERIS plc.
STERIS plc (NYSE:STE) led the NYSE gainers with a relatively large price hike in the past couple of weeks. As a...
Steris shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82.
The U.S. death toll from COVID-19 rose above 22,000 on Monday, as President Donald Trump railed against the nation’s top infectious disease expert for suggesting more lives could have been saved if restrictions on movement had been imposed earlier.
DUBLIN, IRELAND, April 30, 2020 -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 fourth.
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
The Food and Drug Administration (FDA) last week issued two emergency use authorizations (EUA) to medical devices allowing them to decontaminate N95 or N95-equivalent respirators so that they can be reused by health care workers. The first EUA was granted to Steris Corp. on April 9; the second on April 11 to Advanced Sterilization Products Inc., which has been owned by Fortive Corp. since 2019. An emergency authorization is not considered an FDA approval but allows health care providers to utilize certain technologies during the COVID-19 pandemic given the lack of alternative options. Since the start of the year, Steris' stock is down 0.5%, shares of Fortive have fallen 21.5%, and the S&P 500 has tumbled 13.6%.
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Revenue as reported for the quarter increased 7% to $823.0 million compared with $768.2 million in the fourth quarter of fiscal 2019, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 8% for the fourth quarter of fiscal 2020.
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.